Pfizer - Collegeville, PA
posted 2 months ago
The incumbent, within the US Market Access Marketing (USMA-M) team, will lead the development and execution of the US access marketing strategy for XELJANZ and VELSIPITY with a focus on achieving profitable access in alignment with Brand goals. This is a unique opportunity to lead Access Marketing for two Priority Brands simultaneously. They will be responsible for the development, creation, approval, and launch of key strategies and tactics designed to educate formulary and access decision makers and ensure optimal access for VELSIPITY as well as LOE planning for Xeljanz including portfolio access implications. The Access Marketer will advocate for access, reimbursement, and policy approaches that support Brand uptake and performance. The US Market Access Marketer will be part of the USMA Marketing team and will liaise with the Brand team for I&I Rheumatology/GI franchise and work across the USMA organization as appropriate including, Payer Account management, Market Access Strategy Pricing and Analytics, Market Access Operations, Channel Management. This role is an opportunity for a talented, high-energy colleague to join the US Market Access Marketing team for two Priority Brands with extensive and frequent exposure to senior levels of management. The USMA Access Marketer will ensure successful access for VELSIPITY including national PBM adoption and rapid custom client pull-through in order for the brand to meet revenue goals and to develop annual Access Plans. They will also ensure successful access and revenue maximization for XELJANZ as the brand approaches LOE including brand continuity planning and portfolio access implications post LOE. The role requires collaboration with key stakeholders to set and monitor access goals and plan strategies accordingly to maximize revenue and GTN. The Access Marketer will update VELSIPITY and XELJANZ Value proposition and value narrative to engage payer customers in their decision-making based on clinical and economic value. They will develop and implement quarterly POA priorities with the Account Management team and proactively identify and address key barriers to access and performance by applying advanced understanding of and experience with contracting and pricing strategies, analytics, and market trends across brand lifecycle and market channels. Through the value proposition narrative, the Access Marketer will ensure payer and access decision makers assess the potential cost savings and evaluate the economic impact of incorporating, or maintaining, XELJANZ and VELSIPITY on their formularies. They will drive and inform key decisions regarding XELJANZ and VELSIPITY access assessments for and negotiations in a complex and continuously evolving market. The role also involves assessing sustainable pricing through selective contracting that is informed by advanced competitive intelligence and analytics, managing the USMA Brand budget, and securing appropriate funding for Brand specific strategies and tactics from commercial partners per SOP. Finally, the Access Marketer will lead and manage the Brand Access Matrix Team and associated deliverables, as well as lead customer value partnership opportunities for XELJANZ and VELSIPITY in collaboration with Customer facing teams and in partnership with USMA Customer Marketing.